首页> 外文OA文献 >Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors

【2h】

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors

机译：肺腺癌的耐用临床响应，胃肠腺癌/ T790M / Trans-C797s的组合治疗第一代和第三代EGFR酪氨酸激酶抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zhen Zhou; Yi Zhao; Shengping Shen; Linping Gu; Xiaomin Niu; Yunhua Xu; Tengfei Zhang; Jianxing Xiang; Xinru Mao; Shun Lu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 第一代酪氨酸激酶抑制剂治疗中发生进展的非小细胞肺癌血浆表皮生长因子受体(EGFR) T790M突变提示了失败部位并预测了临床预后:一项前瞻性观察研究 [J] . Shirong Zhang, Lucheng Zhu, Bing Xia, 癌症（英文版） . 2018,第009期
2. 第一代EGFR酪氨酸激酶抑制剂治疗106例复合EGFR突变肺癌患者:一项单中心临床研究 [J] . Xiangyang Yu, Xuewen Zhang, Zichen Zhang, 癌症（英文版） . 2019,第010期
3. Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors [J] . Zhou Zhen, Zhao Yi, Shen Shengping, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2019,第8期

机译：肺腺癌的耐用临床响应，胃肠腺癌/ T790M / Trans-C797s的组合治疗第一代和第三代EGFR酪氨酸激酶抑制剂
4. Primary Resistance to Combination Therapy with First- and Third-Generation EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in Trans-C797S Mutations with Co-Occurring CTNNB1 Alteration [J] . Jianxin Chen, Junhui Wang, Xilin Wu OncoTargets and therapy . 2020,第2期

机译：用肺腺癌的第一和第三代EGFR酪氨酸激酶抑制剂与共同发生的CTNNB1改变进行肺腺癌的第一和第三代EGFR酪氨酸激酶抑制剂的初步抗肺腺癌/ T790M / Trans-C797s突变
5. Lung Adenocarcinoma Harboring EGFR T790M and In?Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance [J] . Zhen Wang, Jin-Ji Yang, Jie Huang, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：肺腺癌含有EGFR T790M和IN？Trans C797S响应第一代和第三代EGFR TKI的组合治疗，并在抗性下移动等位基因配置
6. Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma [C] . Yeul Hong Kim, Hye Sook Kim, Jae Sook Sung, Molecular Medicine TRI-CON. . 2014

机译：下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
7. EGFR in Early Non-Small Cell Lung Cancer: Tyrosine Kinase Inhibition in a Neoadjuvant Trial. [D] . Lara-Guerra, Humberto. 2011

机译：早期非小细胞肺癌中的EGFR：新辅助试验中酪氨酸激酶抑制作用。
8. Primary Resistance to Combination Therapy with First- and Third-Generation EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in Trans-C797S Mutations with Co-Occurring CTNNB1 Alteration [O] . Jianxin Chen, Junhui Wang, Xilin Wu 2020

机译：用肺腺癌的第一和第三代EGFR酪氨酸激酶抑制剂与共同发生的CTNNB1改变进行肺腺癌的第一和第三代EGFR酪氨酸激酶抑制剂的初步抗肺腺癌/ T790M / Trans-C797s突变
9. Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy [O] . Xiaofei Wang, Ling Zhou, Jiani C. Yin, 2019

机译：肺腺癌含EGFR 19DEL / C797S / T790M三重突变对Brigatinib和抗EGFR抗体联合治疗作出反应

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅